Adenotonsillectomy with turbinate ablation shows no added benefit for pediatric SDB
This randomized prospective study included 51 children aged 3 to 17 years with sleep-disordered breathing (SDB), nasal obstruction, and turbinate hypertrophy. Participants were randomized to adenotonsillectomy with submucosal ablation of turbinates (AT with SAT) or adenotonsillectomy alone (AT). The primary outcome was change in the sinus and nasal quality of life survey (SN-5) at 3 and 12 months.
At 3 months, the reduction in total SN-5 score was 51% in the AT with SAT group versus 50.1% in the AT alone group (P = .707). At 12 months, the reduction was 52.1% versus 43.6% (P = .225). Neither difference was statistically significant. The visual analog scale (VAS) was a secondary outcome, but specific results were not reported.
Safety and adverse events were not reported in the study. A key limitation is that the SAT group had higher preoperative SN-5 scores compared to the control group, which may have influenced results. The authors note that future research should include an assessment of SDB symptom burden.
For clinicians, it remains uncertain whether SAT performed at the time of AT confers additional improvement in nasal symptoms compared to AT alone. These findings do not support routine addition of SAT in this population.